Category Archives: Pr Newswire

Elevating Portable Power Solutions with Superior Capacity, Versatility, and Eco-Friendly Innovation SYDNEY, July 25, 2024 /PRNewswire/ — Jackery, a global leader in innovative portable power solutions, is excited to announce the launch of its latest products, the Explorer 1000 Plus and Explorer 600 Plus, in the Australian market. These new models are set to redefine […]

H1 2024 profit driven by strong business performance, including 500% rise in crypto derivatives trading, >360% increase in loan volumes[i] and >1,000 daily trades with 20+ B2B partner banks servicing more than a third of Swiss population Sygnum now holds ~$4.5 billion in client assets as well as >$125m USD equivalentcore equity capital, following January $40m capital […]

Sets Final Bid Deadline of July 31, 2024 MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) — The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, […]

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Wednesday, August 7, 2024, to provide a corporate […]

TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) — ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid tumors, today announced investment commitment of €13.5M from the European Innovation Council’s (EIC) Accelerator program, including a grant of €2.5M and a conditional equity investment […]

CAMBRIDGE, Mass., July 24, 2024 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its second quarter 2024 financial results will be released on Wednesday, July 31, 2024, before the U.S. […]

CONSHOHOCKEN, Pa., July 24, 2024 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its second-quarter 2024 financial results on Wednesday, August 7, 2024, prior to the open of the U.S. financial markets. Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial […]

SoniVie announces RDN pilot results, radial access FIH and FDA pivotal IDE approval, initiating the global THRIVE study in US, Europe and Israel TEL AVIV, Israel, July 24, 2024 /PRNewswire/ — SoniVie, which has developed a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, presented on May 15th, 2024 at the […]

‘Gift of Coaching’ program will provide free coaching to nurses, residents, paramedics, Advanced Practice Providers, and allied health professionals to help elevate their professional and personal lives NEW YORK, July 24, 2024 /PRNewswire/ — EZRA, an LHH brand, today launched the Gift of Coaching program to provide free professional coaching, support, and tools to 1,000 U.S.-based […]

Company posts 16% YoY growth with increases in ARR and bookings LONDON, July 24, 2024 /PRNewswire/ — Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, today announced its financial results for the first half of 2024. The company reports 16 percent YoY revenue growth, reflecting continued strong performance and […]